IRTC IRhythm Technologies Inc.

iRhythm Technologies Announces the Appointment of Renee Budig to its Board of Directors

iRhythm Technologies Announces the Appointment of Renee Budig to its Board of Directors

SAN FRANCISCO, April 23, 2020 (GLOBE NEWSWIRE) -- iRhythm Technologies, Inc. (NASDAQ: IRTC), a leading digital health care solutions company focused on the advancement of cardiac care, today announced the appointment of Renee Budig to its Board of Directors effective April 23, 2020. Ms. Budig was appointed as a Class II director and will also serve on the Audit Committee. 

“On behalf of the iRhythm team, I am delighted to welcome Renee to our Board of Directors,” said Kevin King, CEO. “Renee has a very strong finance and operations background as a leader and advisor to a number of successful technology companies. Renee will fill a key role in bringing additional experience and perspectives to iRhythm. We are looking forward to Renee’s contributions to guide iRhythm to continued success and help us scale our operations.”

On her appointment, Ms. Budig commented, “I am thrilled to join the Board of iRhythm, a recognized leader in the digital health space. iRhythm has shown a track record of innovation and is changing the status quo in cardiac monitoring. I am looking forward to contributing my expertise and helping iRhythm continue to grow and scale their digital health platform.”

Following the appointment of Ms. Budig, iRhythm’s Board is comprised of eight directors.

About Renee Budig

Ms. Budig has served as a member of the Board of Directors and as Chair of the Audit Committee of Chegg, Inc. since November 2015. Since September 2012, Ms. Budig has served as the Executive Vice President and Chief Financial Officer of CBS Interactive, a division of ViacomCBS, the world’s largest publisher of premium digital content and a perennial top 10 Internet company. Previously, Ms. Budig served as Chief Financial Officer of Hightail, Inc. (formerly branded YouSendIt and acquired by OpenText), a cloud service that allowed users to send, receive, digitally sign and synchronize files. Prior, Ms. Budig was the Vice President of Finance at Netflix, Inc. and the Vice President of Finance for Veritas Software. Ms. Budig holds a B.S. in Business Administration from the University of California, Berkeley.

                                                              

About iRhythm Technologies, Inc. 

iRhythm is a leading digital health care company redefining the way cardiac arrhythmias are clinically diagnosed. The company combines wearable biosensor devices worn for up to 14 days and cloud-based data analytics with powerful proprietary algorithms that distill data from millions of heartbeats into clinically actionable information. The company believes improvements in arrhythmia detection and characterization have the potential to change clinical management of patients.

Investor Relations Contact:

Lynn Pieper Lewis or Leigh Salvo

(415) 937-5404



                   Media Contact

Saige Smith

(262) 289-7065

   



EN
23/04/2020

Underlying

To request access to management, click here to engage with our
partner Phoenix-IR's CorporateAccessNetwork.com

Reports on IRhythm Technologies Inc.

 PRESS RELEASE

Data presented at ACC.26 further demonstrate the benefits of iRhythm’s...

Data presented at ACC.26 further demonstrate the benefits of iRhythm’s Zio® ambulatory ECG portfolio across multiple patient populations as company launches new digital education platform Data presented at ACC.26 demonstrate a high prevalence of clinically actionable arrhythmias across CKM patient populations using the Zio® ambulatory ECG portfolio.1,2Chief Medical Officer Mintu Turakhia, MD, MS, delivered the 57th Annual Louis F. Bishop Keynote on scaling AI in cardiology and translating advances into clinical practice.iRhythm Academy launch expands access to clinician education at scale i...

 PRESS RELEASE

iRhythm Holdings Appoints Jason Patten to its Board of Directors

iRhythm Holdings Appoints Jason Patten to its Board of Directors SAN FRANCISCO, March 12, 2026 (GLOBE NEWSWIRE) -- iRhythm Holdings, Inc. (NASDAQ: IRTC), a leading digital health care company focused on creating trusted solutions that detect, predict, and prevent disease, is pleased to announce the appointment of Jason Patten to its Board of Directors, effective March 12, 2026. Mr. Patten brings decades of strategic leadership in healthcare, reinforcing iRhythm’s commitment to innovation, operational excellence, and long-term growth. “We are thrilled to welcome Jason Patten to our Board ...

 PRESS RELEASE

iRhythm Holdings Announces Fourth Quarter and Full Year 2025 Financial...

iRhythm Holdings Announces Fourth Quarter and Full Year 2025 Financial Results SAN FRANCISCO, Feb. 19, 2026 (GLOBE NEWSWIRE) -- iRhythm Holdings, Inc. (NASDAQ: IRTC), a leading digital health care company focused on creating trusted solutions that detect, predict, and prevent disease, today reported financial results for the three months and full year ended December 31, 2025. Fourth Quarter 2025 Financial Highlights Revenue of $208.9 million, a 27.1% increase compared to fourth quarter 2024Gross margin of 70.9%, a 90-basis point increase compared to fourth quarter 2024Net income of $5.6...

 PRESS RELEASE

iRhythm Holdings to Report Fourth Quarter and Full Year 2025 Financial...

iRhythm Holdings to Report Fourth Quarter and Full Year 2025 Financial Results on February 19, 2026 SAN FRANCISCO, Feb. 05, 2026 (GLOBE NEWSWIRE) -- (NASDAQ:IRTC), a leading digital health care company focused on creating trusted solutions that detect, prevent, and predict disease, today announced that it will release financial results for the fourth quarter and full year 2025 after the close of trading on Thursday, February 19, 2026. The company’s management team will host a corresponding conference call beginning at 1:30 p.m. PT / 4:30 p.m. ET. Interested parties may access a live and...

 PRESS RELEASE

iRhythm Technologies, Inc. Shares Preliminary Fourth Quarter 2025 High...

iRhythm Technologies, Inc. Shares Preliminary Fourth Quarter 2025 Highlights and Business Update at the 44th Annual J.P. Morgan Healthcare Conference SAN FRANCISCO, Jan. 12, 2026 (GLOBE NEWSWIRE) -- iRhythm Technologies, Inc. (NASDAQ:IRTC) a leading digital health care company focused on creating trusted solutions that detect, predict, and prevent disease, today announced preliminary fourth quarter operational highlights and a business update at the 44th Annual J.P. Morgan Healthcare Conference. Recent Operational Highlights and Financial Outlook Anticipate full year 2025 revenue to exc...

ResearchPool Subscriptions

Get the most out of your insights

Get in touch